ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

By | May 9, 2022
A new study published in the New England Journal of Medicine has discussed the efficacy and safety profile of the ZF2001 vaccine in adults, based on a randomized, placebo-controlled, multinational, double-blind phase 3 trial.